Related references
Note: Only part of the references are listed.Cilostazol: a Review of Basic Mechanisms and Clinical Uses
Riyad Y. Kherallah et al.
CARDIOVASCULAR DRUGS AND THERAPY (2022)
Liver regeneration: biological and pathological mechanisms and implications
George K. Michalopoulos et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2021)
Patterns of dendritic cell and monocyte subsets are associated with disease severity and mortality in liver cirrhosis patients
Chandra Chiappin Cardoso et al.
SCIENTIFIC REPORTS (2021)
Cellular Mechanisms of Liver Fibrosis
Pragyan Acharya et al.
FRONTIERS IN PHARMACOLOGY (2021)
Macrophages in Chronic Liver Failure: Diversity, Plasticity and Therapeutic Targeting
Arjuna Singanayagam et al.
FRONTIERS IN IMMUNOLOGY (2021)
It's all about the spaces between cells: role of extracellular matrix in liver fibrosis
Amit Khurana et al.
ANNALS OF TRANSLATIONAL MEDICINE (2021)
Nuclear receptors in liver fibrosis
Philipp Koenigshofer et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2021)
Liver Injury and the Macrophage Issue: Molecular and Mechanistic Facts and Their Clinical Relevance
Siyer Roohani et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Farnesoid X receptor (FXR): Structures and ligands
Longying Jiang et al.
COMPUTATIONAL AND STRUCTURAL BIOTECHNOLOGY JOURNAL (2021)
A Deactivation Factor of Fibrogenic Hepatic Stellate Cells Induces Regression of Liver Fibrosis in Mice
Yasuhiro Nakano et al.
HEPATOLOGY (2020)
Mechanisms of liver fibrosis and its role in liver cancer
Debanjan Dhar et al.
EXPERIMENTAL BIOLOGY AND MEDICINE (2020)
Effects of Belapectin, an Inhibitor of Galectin-3, in Patients With Nonalcoholic Steatohepatitis With Cirrhosis and Portal Hypertension
Naga Chalasani et al.
GASTROENTEROLOGY (2020)
Taming the Savage Breast From Within: Transcription Factor 21, a Regulator of Stellate Cell Deactivation
Shuang Wang et al.
HEPATOLOGY (2020)
Hepatitis C Guidance 2019 Update: American Association for the Study of Liver Diseases-Infectious Diseases Society of America Recommendations for Testing, Managing, and Treating Hepatitis C Virus Infection
HEPATOLOGY (2020)
Randomized placebo-controlled trial of emricasan for non-alcoholic steatohepatitis-related cirrhosis with severe portal hypertension
Guadalupe Garcia-Tsao et al.
JOURNAL OF HEPATOLOGY (2020)
Selonsertib for patients with bridging fibrosis or compensated cirrhosis due to NASH: Results from randomized phase III STELLAR trials
Stephen A. Harrison et al.
JOURNAL OF HEPATOLOGY (2020)
Selonsertib Inhibits Liver Fibrosis via Downregulation of ASK1/MAPK Pathway of Hepatic Stellate Cells
Young-Chan Yoon et al.
BIOMOLECULES & THERAPEUTICS (2020)
Targeting of Hepatic Macrophages by Therapeutic Nanoparticles
Clara Colino et al.
FRONTIERS IN IMMUNOLOGY (2020)
Genome-wide association study of non-alcoholic fatty liver and steatohepatitis in a histologically characterised cohort
Quentin M. Anstee et al.
JOURNAL OF HEPATOLOGY (2020)
Hepatic benefits of HCV cure
Vincenza Calvaruso et al.
JOURNAL OF HEPATOLOGY (2020)
Organ and tissue fibrosis: Molecular signals, cellular mechanisms and translational implications
Ralf Weiskirchen et al.
MOLECULAR ASPECTS OF MEDICINE (2019)
Immune inflammation indicators and ALBI score to predict liver cancer in HCV-patients treated with direct-acting antivirals
Andrea Casadei Gardini et al.
DIGESTIVE AND LIVER DISEASE (2019)
PNPLA3 variant M148 causes resistance to starvation-mediated lipid droplet autophagy in human hepatocytes
Florentina Negoita et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2019)
PNPLA3, CGI-58, and Inhibition of Hepatic Triglyceride Hydrolysis in Mice
Yang Wang et al.
HEPATOLOGY (2019)
Fibrosis and alcohol-related liver disease
Carolin Lackner et al.
JOURNAL OF HEPATOLOGY (2019)
Activated NK cells kill hepatic stellate cells via p38/PI3K signaling in a TRAIL-involved degranulation manner
Tianyang Li et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2019)
Cilostazol protects rats against alcohol-induced hepatic fibrosis via suppression of TGF-1/CTGF activation and the cAMP/Epac1 pathway
Kun Han et al.
EXPERIMENTAL AND THERAPEUTIC MEDICINE (2019)
The Role of Fibrosis and Liver-Associated Fibroblasts in the Pathogenesis of Hepatocellular Carcinoma
Jacopo Baglieri et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Accumulation of PNPLA3 on lipid droplets is the basis of associated hepatic steatosis
Soumik BasuRay et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)
Regression of fibrosis by cilostazol in a rat model of thioacetamide-induced liver fibrosis: Up regulation of hepatic cAMP, and modulation of inflammatory, oxidative stress and apoptotic biomarkers
Sally A. El Awdan et al.
PLOS ONE (2019)
LECT2, a Ligand for Tie1, Plays a Crucial Role in Liver Fibrogenesis
Meng Xu et al.
CELL (2019)
Costunolide reduces glycolysis-associated activation of hepatic stellate cells via inhibition of hexokinase-2
Dujing Ban et al.
CELLULAR & MOLECULAR BIOLOGY LETTERS (2019)
Neutrophils contribute to spontaneous resolution of liver inflammation and fibrosis via microRNA-223
Carolina Jimenez Calvente et al.
JOURNAL OF CLINICAL INVESTIGATION (2019)
Single-Cell Transcriptomics Uncovers Zonation of Function in the Mesenchyme during Liver Fibrosis
Ross Dobie et al.
CELL REPORTS (2019)
Mechanisms Underlying Cell Therapy in Liver Fibrosis: An Overview
Daphne Pinheiro et al.
CELLS (2019)
Is This the Last Requiem for Simtuzumab?
Peter Fickert
HEPATOLOGY (2019)
Strategies to improve the efficiency of mesenchymal stem cell transplantation for reversal of liver fibrosis
Chenxia Hu et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2019)
A randomized, placebo-controlled trial of emricasan in patients with NASH and F1-F3 fibrosis
Stephen A. Harrison et al.
JOURNAL OF HEPATOLOGY (2019)
Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial
Zobair M. Younossi et al.
LANCET (2019)
Therapeutic Targeting of Hepatic Macrophages for the Treatment of Liver Diseases
Daphne van der Heide et al.
FRONTIERS IN IMMUNOLOGY (2019)
Emricasan Ameliorates Portal Hypertension and Liver Fibrosis in Cirrhotic Rats Through a Hepatocyte-Mediated Paracrine Mechanism
Jordi Gracia-Sancho et al.
HEPATOLOGY COMMUNICATIONS (2019)
Combatting Fibrosis: Exosome-Based Therapies in the Regression of Liver Fibrosis
Li Chen et al.
HEPATOLOGY COMMUNICATIONS (2019)
The role of the apoptosis-related protein BCL-B in the regulation of mitophagy in hepatic stellate cells during the regression of liver fibrosis
Qian Ding et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2019)
PNPLA3-A Potential Therapeutic Target for Personalized Treatment of Chronic Liver Disease
Xiaocheng Charlie Dong
FRONTIERS IN MEDICINE (2019)
γδT Cells Suppress Liver Fibrosis via Strong Cytolysis and Enhanced NK Cell-Mediated Cytotoxicity Against Hepatic Stellate Cells
Meifang Liu et al.
FRONTIERS IN IMMUNOLOGY (2019)
The ASK1 inhibitor selonsertib in patients with nonalcoholic steatohepatitis: A randomized, phase 2 trial
Rohit Loomba et al.
HEPATOLOGY (2018)
Hepatic recruitment of CD11b+Ly6C+ inflammatory monocytes promotes hepatic ischemia/reperfusion injury
Peng Song et al.
INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE (2018)
Extrahepatic angiogenesis hinders recovery of portal hypertension and collaterals in rats with cirrhosis resolution
Shao-Jung Hsu et al.
CLINICAL SCIENCE (2018)
Simtuzumab Is Ineffective for Patients With Bridging Fibrosis or Compensated Cirrhosis Caused by Nonalcoholic Steatohepatitis
Stephen A. Harrison et al.
GASTROENTEROLOGY (2018)
Hedgehog-YAP Signaling Pathway Regulates Glutaminolysis to Control Activation of Hepatic Stellate Cells
Kuo Du et al.
GASTROENTEROLOGY (2018)
Incidence of Hepatocellular Carcinoma After Direct Antiviral Therapy for HCV in Patients With Cirrhosis Included in Surveillance Programs
Pierre Nahon et al.
GASTROENTEROLOGY (2018)
P300 Acetyltransferase Mediates Stiffness-Induced Activation of Hepatic Stellate Cells Into Tumor-Promoting Myofibroblasts
Changwei Dou et al.
GASTROENTEROLOGY (2018)
Liver Angiopoietin-2 Is a Key Predictor of De Novo or Recurrent Hepatocellular Cancer After Hepatitis C Virus Direct-Acting Antivirals
Francesca Faillaci et al.
HEPATOLOGY (2018)
B lymphocytes limit senescence-driven fibrosis resolution and favor hepatocarcinogenesis in mouse liver injury
Francesca Faggioli et al.
HEPATOLOGY (2018)
Therapeutic inhibition of inflammatory monocyte recruitment reduces steatohepatitis and liver fibrosis
Oliver Krenkel et al.
HEPATOLOGY (2018)
A randomized, placebo-controlled trial of cenicriviroc for treatment of nonalcoholic steatohepatitis with fibrosis
Scott L. Friedman et al.
HEPATOLOGY (2018)
Kupffer-derived matrix metalloproteinase-9 contributes to liver fibrosis resolution
Min Feng et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2018)
The balancing act of the liver: tissue regeneration versus fibrosis
Lucia Cordero-Espinoza et al.
JOURNAL OF CLINICAL INVESTIGATION (2018)
Resolution of organ fibrosis
Joon-Il Jun et al.
JOURNAL OF CLINICAL INVESTIGATION (2018)
A study about immunomodulatory effect and efficacy and prognosis of human umbilical cord mesenchymal stem cells in patients with chronic hepatitis B-induced decompensated liver cirrhosis
Xueqing Fang et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2018)
Determinants of fibrosis progression and regression in NASH
Detlef Schuppan et al.
JOURNAL OF HEPATOLOGY (2018)
IL-22 inactivates hepatic stellate cells via downregulation of the TGF-1/Notch signaling pathway
Enran Chen et al.
MOLECULAR MEDICINE REPORTS (2018)
Interleukin-10 promotes primary rat hepatic stellate cell senescence by upregulating the expression levels of p53 and p21
Yue-Hong Huang et al.
MOLECULAR MEDICINE REPORTS (2018)
Trichostatin A inhibits the activation of Hepatic stellate cells by Increasing C/EBP-α Acetylation in vivo and in vitro
Di Ding et al.
SCIENTIFIC REPORTS (2018)
MicroRNA-145 Increases the Apoptosis of Activated Hepatic Stellate Cells Induced by TRAIL through NF-κB Signaling Pathway
Junfa Yang et al.
FRONTIERS IN PHARMACOLOGY (2018)
Long-term changes in liver elasticity in hepatitis C virus-infected patients with sustained virologic response after treatment with direct-acting antivirals
Veronika Pietsch et al.
UNITED EUROPEAN GASTROENTEROLOGY JOURNAL (2018)
IL-4 Receptor Alpha Signaling through Macrophages Differentially Regulates Liver Fibrosis Progression and Reversal
Shih-Yen Weng et al.
EBIOMEDICINE (2018)
Apoptosis and necroptosis in the liver: a matter of life and death
Robert F. Schwabe et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2018)
Carcinogenesis on the background of liver fibrosis: Implications for the management of hepatocellular cancer
Joanne Marie O'Rourke et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2018)
Single cell RNA sequencing of human liver reveals distinct intrahepatic macrophage populations
Sonya A. MacParland et al.
NATURE COMMUNICATIONS (2018)
The Role of Monocytes and Macrophages in Acute and Acute-on-Chronic Liver Failure
Evangelos Triantafyllou et al.
FRONTIERS IN IMMUNOLOGY (2018)
Role of Metabolism in Hepatic Stellate Cell Activation and Fibrogenesis
Wei Hou et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2018)
Tumor Necrosis Factor-alpha-Mediated Hepatocyte Apoptosis Stimulates Fibrosis in the Steatotic Liver in Mice
Yosuke Osawa et al.
HEPATOLOGY COMMUNICATIONS (2018)
Type 2 immunity in tissue repair and fibrosis
Richard L. Gieseck et al.
NATURE REVIEWS IMMUNOLOGY (2018)
Altered AKAP12 expression in portal fibroblasts and liver sinusoids mediates transition from hepatic fibrogenesis to fibrosis resolution
Hye Shin Lee et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2018)
Senescence in hepatic stellate cells as a mechanism of liver fibrosis reversal: a putative synergy between retinoic acid and PPAR-gamma signalings
Concetta Panebianco et al.
CLINICAL AND EXPERIMENTAL MEDICINE (2017)
Neutrophils orchestrate post-myocardial infarction healing by polarizing macrophages towards a reparative phenotype
Michael Horckmans et al.
EUROPEAN HEART JOURNAL (2017)
Impact of viral eradication with sofosbuvir-based therapy on the outcome of post-transplant hepatitis C with severe fibrosis
Silvia Martini et al.
LIVER INTERNATIONAL (2017)
Modulation of hepatic stellate cells and reversibility of hepatic fibrosis
Yu Huang et al.
EXPERIMENTAL CELL RESEARCH (2017)
Selective targeting of lysyl oxidase-like 2 (LOXL2) suppresses hepatic fibrosis progression and accelerates its reversal
Naoki Ikenaga et al.
GUT (2017)
The PNPLA3 I148M Variant Modulates the Fibrogenic Phenotype of Human Hepatic Stellate Cells
Francesca Virginia Bruschi et al.
HEPATOLOGY (2017)
The PNPLA3 Variant Associated With Fatty Liver Disease (I148M) Accumulates on Lipid Droplets by Evading Ubiquitylation
Soumik BasuRay et al.
HEPATOLOGY (2017)
Liver inflammation and fibrosis
Yukinori Koyama et al.
JOURNAL OF CLINICAL INVESTIGATION (2017)
Targeting hepatic macrophages to treat liver diseases
Frank Tacke
JOURNAL OF HEPATOLOGY (2017)
Regulation of hepatic stellate cell proliferation and activation by glutamine metabolism
Jiang Li et al.
PLOS ONE (2017)
Macrophage Phenotype in Liver Injury and Repair
Y-Y Sun et al.
SCANDINAVIAN JOURNAL OF IMMUNOLOGY (2017)
Disease Reversibility in Patients With Post-Hepatitis C Cirrhosis: Is the Point of No Return the Same Before and After Liver Transplantation? A Review
Carmen Vinaixa et al.
TRANSPLANTATION (2017)
In vivo hepatic differentiation potential of human umbilical cord-derived mesenchymal stem cells: Therapeutic effect on liver fibrosis/cirrhosis
Guo-Zun Zhang et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2017)
Selective inhibitor of Wnt/β-catenin/CBP signaling ameliorates hepatitis C virus-induced liver fibrosis in mouse model
Yuko Tokunaga et al.
SCIENTIFIC REPORTS (2017)
The Human Amnion Epithelial Cell Secretome Decreases Hepatic Fibrosis in Mice with Chronic Liver Fibrosis
Majid Alhomrani et al.
FRONTIERS IN PHARMACOLOGY (2017)
Reversal of liver cirrhosis: current evidence and expectations
Young Kul Jung et al.
KOREAN JOURNAL OF INTERNAL MEDICINE (2017)
Cilostazol attenuates intimal hyperplasia in a mouse model of chronic kidney disease
Wiwat Chancharoenthana et al.
PLOS ONE (2017)
The good and the bad collagens of fibrosis - Their role in signaling and organ function
M. A. Karsdal et al.
ADVANCED DRUG DELIVERY REVIEWS (2017)
Mesenchymal stem cell-derived exosomes as a new therapeutic strategy for liver diseases
Guohua Lou et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2017)
Reversal of liver fibrosis: From fiction to reality
Miguel Eugenio Zoubek et al.
BEST PRACTICE & RESEARCH CLINICAL GASTROENTEROLOGY (2017)
Neutrophil microvesicles resolve gout by inhibiting C5a-mediated priming of the inflammasome
Arun Cumpelik et al.
ANNALS OF THE RHEUMATIC DISEASES (2016)
Exosomes from hypoxic endothelial cells have increased collagen crosslinking activity through up-regulation of lysyl oxidase-like 2
Olivier G. de Jong et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2016)
Randomised clinical study: GR-MD-02, a galectin-3 inhibitor, vs. placebo in patients having non-alcoholic steatohepatitis with advanced fibrosis
S. A. Harrison et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2016)
Cyclooxygenase-2 contributes to the selective induction of cell death by the endocannabinoid 2-arachidonoyl glycerol in hepatic stellate cells
S. V. Siegmund et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2016)
Direct Reprogramming of Hepatic Myofibroblasts into Hepatocytes In Vivo Attenuates Liver Fibrosis
Guangqi Song et al.
CELL STEM CELL (2016)
Novel Aspects in the Pathogenesis of Nonalcoholic Steatohepatitis
A. Gentilini et al.
CURRENT MOLECULAR MEDICINE (2016)
Differential gene expression in human, murine, and cell line-derived macrophages upon polarization
Kara L. Spiller et al.
EXPERIMENTAL CELL RESEARCH (2016)
Systemic PEGylated TRAIL Treatment Ameliorates Liver Cirrhosis in Rats by Eliminating Activated Hepatic Stellate Cells
Yumin Oh et al.
HEPATOLOGY (2016)
Transplantation With Autologous Bone Marrow-Derived Mesenchymal Stem Cells for Alcoholic Cirrhosis: Phase 2 Trial
Ki Tae Suk et al.
HEPATOLOGY (2016)
Gradually softening hydrogels for modeling hepatic stellate cell behavior during fibrosis regression
Steven R. Caliari et al.
INTEGRATIVE BIOLOGY (2016)
Molecular Pathogenesis of NASH
Alessandra Caligiuri et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2016)
Reversion of disease manifestations after HCV eradication
Adriaan J. van der Meer et al.
JOURNAL OF HEPATOLOGY (2016)
Hepatic stellate cell transdifferentiation involves genome-wide remodeling of the DNA methylation landscape
Agata Page et al.
JOURNAL OF HEPATOLOGY (2016)
Sustained virologic response to interferon-free therapies ameliorates HCV-induced portal hypertension
Mattias Mandorfer et al.
JOURNAL OF HEPATOLOGY (2016)
Sinusoidal communication in liver fibrosis and regeneration
Giusi Marrone et al.
JOURNAL OF HEPATOLOGY (2016)
Therapeutic effect of renin angiotensin system inhibitors on liver fibrosis
Qianqian Zhu et al.
JOURNAL OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM (2016)
Regression of fibrosis and portal hypertension in HCV-associated cirrhosis and sustained virologic response after interferon-free antiviral therapy
V. Knop et al.
JOURNAL OF VIRAL HEPATITIS (2016)
DAAs Rapidly Reduce Inflammation but Increase Serum VEGF Level: A Rationale for Tumor Risk during Anti-HCV Treatment
Rosanna Villani et al.
PLOS ONE (2016)
Antifibrotic Effects of the Dual CCR2/CCR5 Antagonist Cenicriviroc in Animal Models of Liver and Kidney Fibrosis
Eric Lefebvre et al.
PLOS ONE (2016)
Liver X receptor α is essential for the capillarization of liver sinusoidal endothelial cells in liver injury
Yan Xing et al.
SCIENTIFIC REPORTS (2016)
Curcumin regulates peroxisome proliferator-activated receptor-γ coactivator-1α expression by AMPK pathway in hepatic stellate cells in vitro
Xuguang Zhai et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2015)
Resolution of liver fibrosis requires myeloid cell-driven sinusoidal angiogenesis
Chahrazade Kantari-Mimoun et al.
HEPATOLOGY (2015)
Hepatology Snapshot: Mechanisms of liver fibrosis resolution
Frank Tacke et al.
JOURNAL OF HEPATOLOGY (2015)
Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial
Brent A. Neuschwander-Tetri et al.
LANCET (2015)
Genome-wide analysis of DNA methylation and gene expression patterns in purified, uncultured human liver cells and activated hepatic stellate cells
Adil El Taghdouini et al.
ONCOTARGET (2015)
MicroRNA125b-mediated Hedgehog signaling influences liver regeneration by chorionic plate-derived mesenchymal stem cells
Jeongeun Hyun et al.
SCIENTIFIC REPORTS (2015)
Tonsil-derived Mesenchymal Stem Cells Ameliorate CCl4-induced Liver Fibrosis in Mice via Autophagy Activation
Minhwa Park et al.
SCIENTIFIC REPORTS (2015)
Macrophage migration inhibitory factor is required for recruitment of scar-associated macrophages during liver fibrosis
Mark A. Barnes et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2015)
Celecoxib derivative OSU-03012 inhibits the proliferation and activation of hepatic stellate cells by inducing cell senescence
Jun Zhang et al.
MOLECULAR MEDICINE REPORTS (2015)
Epigenetic Changes during Hepatic Stellate Cell Activation
Silke Goetze et al.
PLOS ONE (2015)
Cirrhosis in children and adolescents: An overview
Raquel Borges Pinto et al.
WORLD JOURNAL OF HEPATOLOGY (2015)
In vitro reversion of activated primary human hepatic stellate cells
Adil El Taghdouini et al.
FIBROGENESIS & TISSUE REPAIR (2015)
Reversal, maintenance or progression: What happens to the liver after a virologic cure of hepatitis C?
Youngmin A. Lee et al.
ANTIVIRAL RESEARCH (2014)
A new histone deacetylase inhibitor improves liver fibrosis in BDL rats through suppression of hepatic stellate cells
Ki Cheong Park et al.
BRITISH JOURNAL OF PHARMACOLOGY (2014)
Roles for Chemokines in Liver Disease
Fabio Marra et al.
GASTROENTEROLOGY (2014)
A Histologic Scoring System for Prognosis of Patients With Alcoholic Hepatitis
Jose Altamirano et al.
GASTROENTEROLOGY (2014)
Vascular Endothelial Growth Factor Promotes Fibrosis Resolution and Repair in Mice
Liu Yang et al.
GASTROENTEROLOGY (2014)
IL-30 (IL27p28) Attenuates Liver Fibrosis Through Inducing NKG2D-Rae1 Interaction Between NKT and Activated Hepatic Stellate Cells in Mice
Abhisek Mitra et al.
HEPATOLOGY (2014)
Cilostazol attenuates hepatic stellate cell activation and protects mice against carbon tetrachloride-induced liver fibrosis
Shunichi Saito et al.
HEPATOLOGY RESEARCH (2014)
Randomized trial of autologous bone marrow mesenchymal stem cells transplantation for hepatitis B virus cirrhosis: Regulation of Treg/Th17 cells
Lanman Xu et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2014)
Macrophage heterogeneity in liver injury and fibrosis
Frank Tacke et al.
JOURNAL OF HEPATOLOGY (2014)
Origin of myofibroblasts in the fibrotic liver in mice
Keiko Iwaisako et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Exosomes mediate intercellular transfer of pro-fibrogenic connective tissue growth factor (CCN2) between hepatic stellate cells, the principal fibrotic cells in the liver
Alyssa Charrier et al.
SURGERY (2014)
Efficacy of cilostazol on platelet reactivity and cardiovascular outcomes in patients undergoing percutaneous coronary intervention: insights from a meta-analysis of randomised trials
Sripal Bangalore et al.
OPEN HEART (2014)
Genetic Diseases That Predispose to Early Liver Cirrhosis
Manuela Scorza et al.
INTERNATIONAL JOURNAL OF HEPATOLOGY (2014)
Binge Ethanol-Induced HDAC3 Down-Regulates Cpt1α Expression Leading to Hepatic Steatosis and Injury
Irina Kirpich et al.
ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH (2013)
Natural killer and natural killer T cells in liver fibrosis
Bin Gao et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2013)
Nilotinib induces apoptosis and autophagic cell death of activated hepatic stellate cells via inhibition of histone deacetylases
Mohamed E. Shaker et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2013)
PNPLA3/adiponutrin functions in lipid droplet formation
Zeina Chamoun et al.
BIOLOGY OF THE CELL (2013)
Clearance of activated stellate cells for hepatic fibrosis regression: Molecular basis and translational potential
Desong Kong et al.
BIOMEDICINE & PHARMACOTHERAPY (2013)
A novel murine model to deplete hepatic stellate cells uncovers their role in amplifying liver damage in mice
Juan E. Puche et al.
HEPATOLOGY (2013)
Interleukin-33-Dependent Innate Lymphoid Cells Mediate Hepatic Fibrosis
Tamar Mchedlidze et al.
IMMUNITY (2013)
Adverse effects of cilostazol on left ventricular function in a patient with a sigmoid shaped interventricular septum
Tomoko Umazume et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2013)
miR-122 regulates collagen production via targeting hepatic stellate cells and suppressing P4HA1 expression
Jiang Li et al.
JOURNAL OF HEPATOLOGY (2013)
TGF-β1-Containing Exosomes from Injured Epithelial Cells Activate Fibroblasts to Initiate Tissue Regenerative Responses and Fibrosis
Fernanda T. Borges et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2013)
Matricellular Protein CCN1 Promotes Regression of Liver Fibrosis through Induction of Cellular Senescence in Hepatic Myofibroblasts
Ki-Hyun Kim et al.
MOLECULAR AND CELLULAR BIOLOGY (2013)
Regression of cirrhosis during treatment with tenofovir disoproxil fumarate for chronic hepatitis B: a 5-year open-label follow-up study
Patrick Marcellin et al.
LANCET (2013)
A histone deacetylase inhibitor, largazole, decreases liver fibrosis and angiogenesis by inhibiting transforming growth factor-β and vascular endothelial growth factor signalling
Yuqing Liu et al.
LIVER INTERNATIONAL (2013)
Identification of Diverse Lipid Droplet Targeting Motifs in the PNPLA Family of Triglyceride Lipases
Sricharan Murugesan et al.
PLOS ONE (2013)
Regression of Fibrosis and Reversal of Cirrhosis in Rats by Galectin Inhibitors in Thioacetamide-Induced Liver Disease
Peter G. Traber et al.
PLOS ONE (2013)
Spiruchostatin A Inhibits Proliferation and Differentiation of Fibroblasts from Patients with Pulmonary Fibrosis
Elizabeth R. Davies et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2012)
cAMP and Epac in the regulation of tissue fibrosis
Paul A. Insel et al.
BRITISH JOURNAL OF PHARMACOLOGY (2012)
Sterile Inflammation in the Liver
Paul Kubes et al.
GASTROENTEROLOGY (2012)
Role of Differentiation of Liver Sinusoidal Endothelial Cells in Progression and Regression of Hepatic Fibrosis in Rats
Guanhua Xie et al.
GASTROENTEROLOGY (2012)
Deactivation of Hepatic Stellate Cells During Liver Fibrosis Resolution in Mice
Juliane S. Troeger et al.
GASTROENTEROLOGY (2012)
Pharmacological inhibition of the chemokine CCL2 (MCP-1) diminishes liver macrophage infiltration and steatohepatitis in chronic hepatic injury
Christer Baeck et al.
GUT (2012)
Elastin accumulation is regulated at the level of degradation by macrophage metalloelastase (MMP-12) during experimental liver fibrosis
Antonella Pellicoro et al.
HEPATOLOGY (2012)
Interleukin-22 induces hepatic stellate cell senescence and restricts liver fibrosis in mice
Xiaoni Kong et al.
HEPATOLOGY (2012)
A morphometric and immunohistochemical study to assess the benefit of a sustained virological response in hepatitis C virus patients with cirrhosis
Roberta D'Ambrosio et al.
HEPATOLOGY (2012)
Human umbilical cord mesenchymal stem cells improve liver function and ascites in decompensated liver cirrhosis patients
Zheng Zhang et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2012)
What's new in liver fibrosis? The origin of myofibroblasts in liver fibrosis
Keiko Iwaisako et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2012)
NK cells from HCV-infected patients effectively induce apoptosis of activated primary human hepatic stellate cells in a TRAIL-, FasL- and NKG2D-dependent manner
Andreas Glaessner et al.
LABORATORY INVESTIGATION (2012)
Multigenerational epigenetic adaptation of the hepatic wound-healing response
Muejdat Zeybel et al.
NATURE MEDICINE (2012)
Mechanisms of fibrosis: therapeutic translation for fibrotic disease
Thomas A. Wynn et al.
NATURE MEDICINE (2012)
Myofibroblasts revert to an inactive phenotype during regression of liver fibrosis
Tatiana Kisseleva et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Differential Ly-6C expression identifies the recruited macrophage phenotype, which orchestrates the regression of murine liver fibrosis
Prakash Ramachandran et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
DNMT1-mediated PTEN hypermethylation confers hepatic stellate cell activation and liver fibrogenesis in rats
Er-Bao Bian et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2012)
Functional role of monocytes and macrophages for the inflammatory response in acute liver injury
Henning W. Zimmermann et al.
FRONTIERS IN PHYSIOLOGY (2012)
Airway remodeling in murine asthma correlates with a defect in PGE2 synthesis by lung fibroblasts
Camila Leindecker Stumm et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2011)
Liver X Receptor Signaling Is a Determinant of Stellate Cell Activation and Susceptibility to Fibrotic Liver Disease
Simon W. Beaven et al.
GASTROENTEROLOGY (2011)
Suppression of Innate Immunity (Natural Killer Cell/Interferon-γ) in the Advanced Stages of Liver Fibrosis in Mice
Won-Il Jeong et al.
HEPATOLOGY (2011)
Sodium valproate blocks the transforming growth factor (TGF)-β1 autocrine loop and attenuates the TGF-β1-induced collagen synthesis in a human hepatic stellate cell line
Toshifumi Watanabe et al.
INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE (2011)
Expression and Characterization of a PNPLA3 Protein Isoform (I148M) Associated with Nonalcoholic Fatty Liver Disease
Yongcheng Huang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Four faces of cellular senescence
Francis Rodier et al.
JOURNAL OF CELL BIOLOGY (2011)
The liver X receptor in hepatic stellate cells: A novel antifibrogenic target?
Ariane Mallat et al.
JOURNAL OF HEPATOLOGY (2011)
Patatin-Like Phospholipase Domain-Containing 3/Adiponutrin Deficiency in Mice Is Not Associated with Fatty Liver Disease
Weiqin Chen et al.
HEPATOLOGY (2010)
A Sequence Variation (I148M) in PNPLA3 Associated with Nonalcoholic Fatty Liver Disease Disrupts Triglyceride Hydrolysis
Shaoqing He et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
β-Catenin Regulates Mesenchymal Progenitor Cell Differentiation During Hepatogenesis
Tove Berg et al.
JOURNAL OF SURGICAL RESEARCH (2010)
Immediate Listing for Liver Transplantation Versus Standard Care for Child-Pugh Stage B Alcoholic Cirrhosis A Randomized Trial
Claire Vanlemmens et al.
ANNALS OF INTERNAL MEDICINE (2009)
Down-regulation of FoxO-dependent c-FLIP expression mediates TRAIL-induced apoptosis in activated hepatic stellate cells
Soo-Jung Park et al.
CELLULAR SIGNALLING (2009)
Liver natural killer and natural killer T cells: immunobiology and emerging roles in liver diseases
Bin Gao et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2009)
Inhibition of histone deacetylase activity attenuates renal fibroblast activation and interstitial fibrosis in obstructive nephropathy
Maoyin Pang et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2009)
Neutrophil depletion delays wound repair in aged mice
Naomi Nishio et al.
AGE (2008)
Wnt antagonism inhibits hepatic stellate cell activation and liver fibrosis
Jason H. Cheng et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2008)
Canonical Wnt signaling maintains the quiescent stage of hepatic stellate cells
Claus Kordes et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2008)
Senescence of activated stellate cells limits liver fibrosis
Valery Krizhanovsky et al.
CELL (2008)
Mechanisms of fibrogenesis
Tatiana Kisseleva et al.
EXPERIMENTAL BIOLOGY AND MEDICINE (2008)
Cilostazol and peripheral arterial disease
Lyndsay Pearce et al.
EXPERT OPINION ON PHARMACOTHERAPY (2008)
Effectiveness of antiplatelet drugs against experimental non-alcoholic fatty liver disease
K. Fujita et al.
GUT (2008)
Farnesoid X Receptor Antagonizes Nuclear Factor κB in Hepatic Inflammatory Response
Yan-Dong Wang et al.
HEPATOLOGY (2008)
Resolution of liver cirrhosis using vitamin A-coupled liposomes to deliver siRNA against a collagen-specific chaperone
Yasushi Sato et al.
NATURE BIOTECHNOLOGY (2008)
Hepatic stellate cells: Protean, multifunctional, and enigmatic cells of the liver
Scott L. Friedman
PHYSIOLOGICAL REVIEWS (2008)
Exploring the full spectrum of macrophage activation
David M. Mosser et al.
NATURE REVIEWS IMMUNOLOGY (2008)
TLR4 enhances TGF-β signaling and hepatic fibrosis
Ekihiro Seki et al.
NATURE MEDICINE (2007)
Scar-associated macrophages are a major source of hepatic matrix metalloproteinase-13 and facilitate the resolution of murine hepatic fibrosis
Jonathan A. Fallowfield et al.
JOURNAL OF IMMUNOLOGY (2007)
Isozymes of plant hexokinase: Occurrence, properties and functions
Eric Claeyssen et al.
PHYTOCHEMISTRY (2007)
Cellular senescence: when bad things happen to good cells
Judith Campisi et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2007)
Nuclear bile acid receptor FXR as pharmacological target: Are we there yet?
Salvatore Modica et al.
FEBS LETTERS (2006)
Hepatic stellate cells and the reversal of fibrosis
Tatiana Kisseleva et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2006)
Gene expression profile of quiescent and activated rat hepatic stellate-cells implicates Wnt signaling pathway in activation
Feng Jiang et al.
JOURNAL OF HEPATOLOGY (2006)
Phagocytosis of apoptotic bodies by hepatic stellate cells induces NADPH oxidase and is associated with liver fibrosis in vivo
SS Zhan et al.
HEPATOLOGY (2006)
Activation of the liver X receptor protects against hepatic injury in endotoxemia by suppressing Kupffer cell activation
YY Wang et al.
SHOCK (2006)
Natural killer cells ameliorate liver fibrosis by killing activated stellate cells in NKG2D-dependent and tumor necrosis factor-related apoptosis-inducing ligand-dependent manners
S Radaeva et al.
GASTROENTEROLOGY (2006)
Monocyte and macrophage heterogeneity
S Gordon et al.
NATURE REVIEWS IMMUNOLOGY (2005)
Adipogenic transcriptional regulation of hepatic stellate cells
HY She et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Selective depletion of macrophages reveals distinct, opposing roles during liver injury and repair
JS Duffield et al.
JOURNAL OF CLINICAL INVESTIGATION (2005)
Fibrosis in chronic liver diseases: diagnosis and management
M Pinzani et al.
JOURNAL OF HEPATOLOGY (2005)
Cirrhosis reversal: a duel between dogma and myth
VJ Desmet et al.
JOURNAL OF HEPATOLOGY (2004)
Platelet cyclic adenosine monophosphate phosphodiesterases: Targets for regulating platelet-related thrombosis
RW Colman
SEMINARS IN THROMBOSIS AND HEMOSTASIS (2004)
Hepatocellular carcinoma in cirrhosis: Incidence and risk factors
G Fattovich et al.
GASTROENTEROLOGY (2004)
The nuclear receptor SHP mediates inhibition of hepatic stellate cells by FXR and protects against liver fibrosis
S Fiorucci et al.
GASTROENTEROLOGY (2004)
Kupffer cell engulfment of apoptotic bodies stimulates death ligand and cytokine expression
A Canbay et al.
HEPATOLOGY (2003)
Activated human hepatic stellate cells express the renin-angiotensin system and synthesize angiotensin II
R Bataller et al.
GASTROENTEROLOGY (2003)
Apoptotic body engulfment by a human stellate cell line is profibrogenic
A Canbay et al.
LABORATORY INVESTIGATION (2003)
Human hepatic stellate cells express CCR5 and RANTES to induce proliferation and migration
RF Schwabe et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2003)
Histological outcome during long-term lamivudine therapy
JL Dienstag et al.
GASTROENTEROLOGY (2003)
Determinants of early mortality in patients with decompensated chronic hepatitis B treated with antiviral therapy
RJ Fontana et al.
GASTROENTEROLOGY (2002)
Regulation of the murine α2(I) collagen promoter by retinoic acid and retinoid X receptors
L Wang et al.
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (2002)
Effect of angiotensin II type 1 receptor blockade on experimental hepatic fibrogenesis
G Paizis et al.
JOURNAL OF HEPATOLOGY (2001)
Apoptosis of hepatic stellate cells: involvement in resolution of biliary fibrosis and regulation by soluble growth factors
R Issa et al.
GUT (2001)
Regression of liver fibrosis after biliary drainage in patients with chronic pancreatitis and stenosis of the common bile duct
P Hammel et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
Phosphodiesterase 4 inhibitors, structurally unrelated to Rolipram, as promising agents for the treatment of asthma and other pathologies
V Dal Piaz et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2000)
Share Paper
